K36 Therapeutics
Biotechnology, Therapeutics
Founded in 1/1/21
Cambridge, Massachusetts, United States
For Profit
About K36 Therapeutics
K36 Therapeutics mission to translate epigenetic modulation of oncogenic pathways into first-in-class small molecule therapies.
Company Metrics
- Employees: 1-10
- Monthly Visits: None
- Tech Stack: None active products
Financial Information
- Estimated Revenue: $1M to $10M
- Total Funding: 30000000 USD
- Last Funding: 30000000 USD (Series A)
- Funding Status: Early Stage Venture
Technology Stack
K36 Therapeutics actively uses None products in their tech stack.
Market Presence
Industries: Biotechnology, Therapeutics
Headquarters: Cambridge, Massachusetts, United States